R

Remedy Plan Therapeutics

10 employees

Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Cancer Drug Development
Health Diagnostics
Cancer Containment Therapy
Medical
Cancer Stem Cells

Date founded

2011

Funding rounds raised

Total raised

$1.5M

from 1 investors over 1 rounds

R

Remedy Plan Therapeutics raised $1.5M on November 9, 2018

Investors: Schooner Capital

FAQ